The treatment for one type of anemia may be both inappropriate and dangerous for another type of anemia. Anemia Caused by Blood Loss If you suddenly lose a large volume of blood, ...

A post-hoc analysis of the phase 3b JUMP trial assessed outcomes in patients with myelofibrosis and baseline anemia who were treated with ruxolitinib alongside anemia-supportive therapies, according ...

Among the 7MM, Japan accounts for the second highest total aplastic anemia drugs market. The Aplastic Anemia Treatment Market Size in Japan has been assessed to be ~USD 35 million in 2023, expected to ...

Gene therapy has always held enormous promise to correct genetic diseases, but turning that potential into treatments has been challenging.

Sickle cell disease (SCD) is an inherited, lifelong and painful blood disorder in which red blood cells are shaped like ...

Several other medical conditions can mimic the symptoms of low testosterone, including depression, sleep apnea, ...

During a live event, Thomas LeBlanc, MD, MA, discussed the outcomes of the COMMANDS trial of luspatercept in myelodysplastic ...

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 ...

A Northeast Ohio woman and a 22-year-old man from UAE are among the first patients to receive the innovative CRISPR treatment ...

Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the ...

LONDON, GREATER LONDON, UNITED KINGDOM, June 18, 2025 /EINPresswire / -- The Business Research Company's Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

Panelists discuss how risk stratification, symptom burden, and splenomegaly guide treatment decisions for a 68-year-old woman ...